Minor cannabinoids CBG, CBC, CBN, and CBDV have shown promise as anti-cancer agents in the treatment of blood cancer. Cannabinoids are now widely prescribed to palliative cancer patients to help manage symptoms, as well as the side-effects of conventional treatments such as chemotherapy. They have also [...]
The UK’s Food Standards Agency (FSA) has issued its first positive safety assessment for a consortium application in its CBD Novel Foods approval process, seeing the European Industrial Hemp Association’s (EIHA) RP427 application progress to the ‘risk management’ phase. Coming just months after the first two [...]
In one of the first human trials investigating CBG, the cannabinoid has shown promise in reducing anxiety and enhancing memory, without any negative side-effects. Alongside CBD and THC, cannabigerol (CBG) is thought to have its own therapeutic effects, including potential anti-anxiety and antidepressant benefits, although the [...]
In what was thought to be a first for a major mainstream health conference on the continent, cannabis and psychedelic medicine were firmly on the agenda at the inaugural HLTH Europe. One of the leading platforms for global health innovation, HLTH brought its flagship conference to [...]
The Czech government looks to be pursuing a full commercial adult-use cannabis market as part of its ‘Cannabis Management Act’, according to leaked documents seen by Business of Cannabis. It came just days after the architect and driving force behind the cannabis legalisation project, National Drug Coordinator [...]
A new animal study has highlighted the possible benefits of CBD and the diabetes drug, metformin, for treating behavioural difficulties. According to research presented at the Federation of European Neuroscience Societies (FENS) Forum 2024, studies of mouse models of Fragile X syndrome and Phelan-McDermid syndrome show [...]
Six months on from the opening of Europe’s first legal cannabis stores in Switzerland, experts are reporting trends towards regulated sales and ‘lower-risk’ consumption methods, such as edibles and extracts. The first data collected from the Grashaus Project in the canton of Basel-Landschaft, which launched at [...]
Three years ago the toppling of a conservative Government in Germany led to a seminal moment for European cannabis – but there appears to be little chance of a repeat in the continent’s second most populous nation. The UK General Election has seen the Labour Party [...]
While CBD is generally considered to be safe, new animal studies have shown alterations in brains and behaviour in offspring exposed to the cannabinoid during pregnancy. The International Cannabis Policy Study recently reported that one in five pregnant women may be using CBD products, believing that [...]
Experts examine how Medical Cannabis may have the potential to improve the quality of life for individuals with Muscular Dystrophy. The article is an excerpt from Cannabiscientia’s handbook, Principles of Clinical Cannabinology, by Viola Brugnatelli and Fabio Turco. Muscular dystrophy (MD) brings a unique set of [...]
As legal cannabis becomes increasingly available across Europe, the first commercial brainwave analysis device is expected to advance understanding of its effects. Canadian AI neurotechnology company, Zentrela, announced the launch of its brainwave analysis device on the European market at the end of June. The Cognalyzer® [...]
UK life sciences company, Ananda Developments, has announced that its CBD-based drug demonstrated “cardioprotective effects” in a pre-clinical study and may hold promise as a potential treatment for heart failure. The company recently shared results from preclinical studies investigating the efficacy of its Patent Pending formulation, [...]
Cannaray Limited, its medical cannabis subsidiary Therismos, and Canadian ‘aquaponics’ cannabis cultivator Aqualitas are set to merge to create a new international vertically integrated cannabis company. Officially launching at Cannabis Europa this week, the newly combined entity, which reportedly saw combined sales of £40m last year, [...]
A new study suggests that adults aged 65 and older experience “considerable improvements” in their health and wellbeing when prescribed cannabis-based medicines. The use of medical cannabis is said to be on the rise among older individuals, yet little research has been done to understand the [...]
A pilot scheme introducing the legal sale and production of cannabis in the Netherlands is due to be expanded to eight more cities across the country. In December 2023, the Dutch government embarked on a pilot scheme to regulate the production of cannabis to supply the country’s ‘coffeeshops’. [...]
A new research paper has highlighted how many people are still accessing cannabis illegally for medicinal purposes in the UK, over five years on from the law change. Despite medical cannabis being legalised in the UK in 2018, previous reports indicate that a large number of [...]
Script Assist has announced that its medical cannabis technology platform, which aims to enable an efficient medical cannabis journey for clinics, doctors and patients, will be available on a software as a service (SaaS) basis for the first time. With its platform now expanding from a [...]
Lyphe is proud to announce the launch of its new low-cost medical cannabis line, Noidecs Vital, designed to address affordability issues for medical patients. Recognising the financial barriers many patients face in accessing cannabis treatments, the Noidecs Vital line will provide a cost-effective option that does [...]
One in six patients in primary care reported cannabis use, with most using it to manage a symptom or health condition, according to new research. The findings, to be published in JAMA Network Open, by researchers at UCLA, suggest that most patients reported using cannabis for symptom [...]
The first patient to receive medical cannabis flower through the NHS has shared how it helped him manage debilitating side-effects of cancer treatment. In April 2023, Mike Roberts secured the first NHS reimbursement for medical cannabis flower prescribed through a private clinic to manage chemotherapy-induced nausea [...]
A new study using data from the National Survey on Drug Use and Health on men in the US has found a possible association between cannabis use and rates of prostate cancer. Researchers behind the study, published in the journal Biomedicines, observed that individuals who were [...]
Medical cannabis cultivator Glass Pharms has officially delivered its first crop to the first UK-based clinic, marking the first time since medical cannabis was legalised that domestically grown product has been made available to patients. The launch of UK-grown medical cannabis marks a significant milestone in [...]
Top chemists at the University of Sussex are developing new ways of administering cannabis-based medicines which could change the perception of medical cannabis in the UK and finally pave the way for NHS access. While flower floods the UK market and companies compete over who can [...]
A new UK task force, headed up by leading figures in medicine and life sciences, will set out the country’s first comprehensive strategy for cannabinoid research and development. Professor Trevor Jones, formerly Head of R&D at Wellcome and Director General of The Association of the British [...]
A new study has found that cannabis terpenes were as effective as morphine at reducing chronic neuropathic pain, and a combination of the two analgesics enhanced pain relief without negative side effects. Some prior studies have shown that the Cannabis sativa plant and its two primary cannabinoids, tetrahydrocannabinol, [...]
A new study offers some of the first insights into the prevalence of CBD use among adolescents. Since cannabidiol (CBD), the non-intoxicating component of cannabis, was legalised in the United States by the 2018 Farm Bill, products containing the compound have flooded the consumer health sector. [...]
Next month, Slovenian citizens will vote on two referendum measures aimed at changing national cannabis policies. The referendum questions, approved by the Slovenian National Assembly in April, represent potential steps towards comprehensive cannabis reform. Although neither measure is legally binding, their approval could significantly influence future [...]
As the first EU country to legalise adult-use cannabis, Malta is looked on as a frontrunner of European reform, but consumers are still being prosecuted for importing CBD flower due to a legal “grey area”. In February 2022, a Maltese doctor was arrested for drug trafficking. [...]
The results of a newly-published survey show that more than one in five police officers in the UK think medical cannabis is still illegal— and most have received ‘inadequate’ training. Despite medical cannabis being legalised on prescription in the UK in November 2018, the survey highlights [...]
A daily dose of THC was associated with increased survival time in palliative care cancer patients, according to the results of a recent study. Researchers investigating the effects of THC in advanced cancer patients say it could be associated with not only increased survival time, but [...]
Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders, with a number of former GW Pharmaceutical bosses on board. The clinical stage biopharma company, formerly known as Sapient Therapeutics, announced its new name, meaning ‘to unlock’, in a press release on [...]
Sponsored The international Cannabis scene dazzles aficionados with its variety of UK cannabis strains. Connoisseurs remain on a quest, aiming to discover cannabis strains that offer a transcendent experience. These strains are not just a manifestation of superior horticultural achievements. They also symbolise the peak of [...]
The latest UK research points to the potential benefits of medical cannabis in the long-term conditions osteoarthritis and multiple sclerosis (MS). New findings using data collected through the UK Medical Cannabis Patient Registry support the use of medical cannabis in the treatment of osteoarthritis, as well [...]
The UK is the primary driver of new growth in Europe’s medical cannabis market, with sales of medical cannabis greater than expected due to ‘unusually high’ consumption volumes on a per-patient basis. By the end of 2024, for example, 62,960 patients are forecasted to be using [...]
The UK’s Food Standards Agency (FSA) has issued the first two ‘positive safety assessments’ for CBD (cannabidiol) products as part of its years-long novel foods authorisation process. Chanelle McCoy’s subsidiary, Pureis, became the first company in the UK to receive a positive risk assessment for a synthetic CBD [...]
It’s time to ditch the long-held ‘lazy stoner’ stereotype, according to new research, which shows cannabis consumers are not as unmotivated as it suggests. The study, published by the journal Social Psychological and Personality Science, surveyed chronic cannabis users to see what effect getting high has [...]
Integro Clinics is the first UK clinic to expand its services worldwide, to address the challenges for patients travelling to the UK who need access to medicinal cannabis on prescription. For patients who rely on medicinal cannabis, travelling abroad can come with a whole host of [...]
New findings help explain how the lesser-known cannabinoid, CBN, protects the brain against ageing and neurodegeneration—and how it could be used to develop potential therapeutics. One in every 10 individuals above the age of 65 develops an age-related neurological disorder like Alzheimer’s or Parkinson’s, yet treatment [...]
The legalisation of cannabis in the US, and subsequent rise in sales, have not contributed to an increase in substance misuse among adolescents, a new study has found. Researchers from Boston College have used the most recent data on adolescent substance use to evaluate the effect [...]
The national centre of expertise on drugs and drugs law, Release, has launched a new initiative to help protect the rights of medical cannabis patients in the UK. Despite medical cannabis being legal in the UK since November 2018, patients continue to report negative experiences of [...]
Following the landmark legislative change in Germany earlier this month, experts are expecting to see a ripple effect across the continent, with some predicting that Europe could overtake the US as the global leader of cannabis reform. In Berlin this week, for a historical International Cannabis [...]
Greek Health Minister to speak at Cannabis Europa London on Greece’s groundbreaking new medical cannabis programme, joined by Curaleaf executive chairman, Boris Jordan, and former Wimbledon champion, Pat Cash. Cannabis Europa, the premier conference for the emerging European cannabis industry, is thrilled to announce its lineup [...]
The founder of the International Alliance for Cannabinoid Medicine (IACM), Dr Franjo Grotenhermen is one of the world’s leading experts in the field of cannabis medicine. But his own personal health battles are just as remarkable. Dr Franjo Grotenhermen is not your typical doctor. Having worked [...]
A new study has linked the consumption of cannabis for recreational purposes to a reduced risk of cognitive decline. Researchers at Upstate Medical University have found that compared to non-users, non-medical cannabis use, such as for recreational purposes, was significantly associated with 96% decreased odds of [...]
An online crowdfunder has been launched to kickstart a key campaign to generate awareness of prescription cannabis among the general public. The crowdfunder, being run by the Cannabis Industry Council (CIC), aims to raise £20,000 initially to undertake public relations and promotional activity around the existence [...]
A new paper highlights the need for greater public health messaging around the risks of cannabis use disorders among those prescribed it for medicinal purposes. While cannabis can have a wide range of potential therapeutic benefits, like any drug or medication it can have adverse effects [...]
Online medical cannabis clinic, Treat It, has announced its expansion to include specialised psychiatric services amid the UK’s ‘mental health crisis’. The move will enable individuals with conditions such as anxiety, ADHD or PTSD to access treatment through Kanabo Group’s digital health platform, at a time [...]
Following the recent legalisation of medical cannabis in Ukraine, Adam Kavalier PhD, explores what we know about its potential in the treatment of PTSD. Ukrainian President Volodymyr Zelensky recently signed into law reforms on medical Cannabis to provide relief to victims of trauma, resulting from the [...]
A medical cannabis patient has been cleared of charges against him on the grounds that he has a legal prescription, after being pulled over by police for a second time. Nathan Williams was found not guilty of failure to provide a specimen at Welshpool Magistrates Court [...]
Via Business of Cannabis Germany’s Bundesrat (Federal Council) has voted to pass the CanG bill without calling in a mediation committee, meaning the law should come into effect on 1 April, 2024. In perhaps the most important vote on cannabis liberalisation in European history, the German [...]
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
